Stay updated on Biomarker Response to Immunotherapy in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Biomarker Response to Immunotherapy in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Biomarker Response to Immunotherapy in NSCLC Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The page’s footer/update indicator changed from **Revision: v3.5.2** to **Revision: v3.5.3**, reflecting a tooling or presentation version update rather than a change to the underlying study record.
    Difference
    0.1%
    Check dated 2026-04-24T06:32:43.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2. Deleted Revision: v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-17T02:47:18.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    38 days ago
    Change Detected
    Summary
    Revision: v3.5.0 was added and Revision: v3.4.3 was removed.
    Difference
    0.1%
    Check dated 2026-03-19T06:41:40.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-12T02:44:41.000Z thumbnail image
  6. Check
    74 days ago
    Change Detected
    Summary
    Revision updated from v3.4.1 to v3.4.2, indicating a minor maintenance update. No substantive changes to study details, eligibility criteria, or outcomes are apparent from the provided context.
    Difference
    0.1%
    Check dated 2026-02-11T14:06:47.000Z thumbnail image
  7. Check
    81 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.0 to v3.4.1; this change does not alter any study details, eligibility criteria, outcomes, or locations.
    Difference
    0.1%
    Check dated 2026-02-04T10:17:02.000Z thumbnail image

Stay in the know with updates to Biomarker Response to Immunotherapy in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Biomarker Response to Immunotherapy in NSCLC Clinical Trial page.